Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03369925 · ClinicalTrials.gov registry record · NA
Cognitive Effects of Citicoline in Men and Women With Age-Associated Memory Impairment
A NA study, sponsored by Kyowa Hakko Bio Co..
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT03369925: Completed NA study, sponsored by Kyowa Hakko Bio Co..
NCT03369925 is a NA study that has completed, run by Kyowa Hakko Bio Co.. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03369925, a NA study, has completed, sponsored by Kyowa Hakko Bio Co..
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
The objective of this trial is to determine the effects of citicoline on cognitive performance in healthy Men and Women with Age-Associated Memory Impairment compared to a placebo.
Interventions
- DIETARY_SUPPLEMENT Placebo supplement
- DIETARY_SUPPLEMENT Citicoline supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2018-01-02 |
| Est. Completion | 2018-12-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03369925
The ClinicalTrials.gov registry entry for NCT03369925 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kyowa Hakko Bio Co., which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo supplement is the first listed.
NCT03369925 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03369925 about?
NCT03369925 is a clinical study titled "Cognitive Effects of Citicoline in Men and Women With Age-Associated Memory Impairment". The objective of this trial is to determine the effects of citicoline on cognitive performance in healthy Men and Women with Age-Associated Memory Impairment compared to a placebo.
What is the current status of trial NCT03369925?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2018-01-02. Estimated completion is 2018-12-03.
What interventions are being tested in trial NCT03369925?
The interventions under investigation include: Placebo supplement (DIETARY_SUPPLEMENT), Citicoline supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03369925?
This trial is sponsored by Kyowa Hakko Bio Co., which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.